🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Spain / NCT07212283
Recruiting Not applicable

Wise Intervention for Reducing Aggressive Behaviors and Promoting Prosocial Behaviors Toward LGB-TNB Individuals

NCT07212283 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2025-09-18
Last updated
2026-05-01

Condition(s) studied

AggressionAdolescence

Investigational drug(s) / intervention(s)

Wise Intervention LGB-TNBValues alignment wise intervention

Wise Intervention LGB-TNB: The intervention will be designed to reduce aggressive behaviors based on sexual orientation and gender identity and to promote prosocial behaviors toward these individuals. This intervention will include three components: (1) reading scientific studies about people's ability to change. In addition, they will read other studies about how thoughts and emotions influence behavior through brain pathways, and that these pathways can be modified under certain circumstances; (2) reading testimonials that support the idea that people can change. These testimonials include accounts of people who were victims or perpetrators based on sexual orientation and gender identity, including important components of empathy and prosocial behaviors toward the victims. To give credibility to the intervention, they will be informed that these stories were written by other young people who previously participated; and (3) self-persuasion exercises that involve an active commitment to change.

Values alignment wise intervention: This intervention will be based on the same strategies as the experimental intervention, but it will not address aspects related to prosocial behaviors or aggression toward LGB-TNB individuals; instead, it will be applied to improve adolescents' eating habits.

Study summary

This study evaluates the effectiveness of a wise Intervention to reduce aggressive behaviors and promote prosocial behaviors toward LGB-TNB individuals among Spanish adolescents. Half of the participants will receive the experimental intervention, while the other half will receive a control intervention.

Eligibility

Sex
ALL
Min age
14 Years
Max age
18 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Informed consent by the adolescents and their families. * To be fluent in Spanish and/or Euskera. Exclusion Criteria: * Lack of permission by families and the adolescent. * Lack of understanding of the instructions.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Nerea Bilbao BIZKAIA Recruiting

More University of Deusto trials in Spain

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07212283 on ClinicalTrials.gov ↗ ← All trials in Spain